ALK I1171T
|
NSCLC
|
ALK I1171T
|
NSCLC
|
crizotinib Resistant: C3 – Early Trials
|
crizotinib Resistant: C3 – Early Trials
|
ALK I1171T
|
NSCLC
|
ALK I1171T
|
NSCLC
|
ceritinib Sensitive: C3 – Early Trials
|
ceritinib Sensitive: C3 – Early Trials
|
ALK I1171T
|
NSCLC
|
ALK I1171T
|
NSCLC
|
ensartinib Sensitive: C3 – Early Trials
|
ensartinib Sensitive: C3 – Early Trials
|
ALK I1171T
|
NSCLC
|
ALK I1171T
|
NSCLC
|
alectinib Resistant: C4 – Case Studies
|
alectinib Resistant: C4 – Case Studies
|